Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 EX-3.1
- 3.2 EX-3.2
- 4.3 EX-4.3
- 10.5 EX-10.5
- 10.6 EX-10.6
- 99.1 Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Unregistered Sales of Equity Securities; Material Modifications to Rights of Security Holders; Changes in Control of Registrant; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics; Change in Shell Company Status; Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits
- Download Excel data file
- View Excel data file
APGN similar filings
- 25 Jan 23 Apexigen Announces Approximately $2.8 Million
- 14 Nov 22 Changes in Registrant's Certifying Accountant
- 18 Aug 22 Index to Unaudited Condensed Financial Statements
- 4 Aug 22 Entry into a Material Definitive Agreement
- 1 Aug 22 Apexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology Company
- 27 Jul 22 Brookline Capital Acquisition Corp. and Apexigen, Inc. Announce Stockholder Approval of
- 18 Jul 22 Apexigen and Brookline Capital Acquisition Corp. Announce Effectiveness of Registration Statement
Filing view
External links